PARLIAMENTARY WRITTEN QUESTION
Coronavirus Certificates (6 September 2021)

Individuals who took part in clinical trials and received a full dose of the Novavax vaccine can now use the NHS COVID Pass to demonstrate their COVID-19 status. However, it is the decision of the Government of the country the person is travelling to to set their inbound travel policy. The Chief Medical Officer has written to his counterparts in the European Union and European Economic Community and discussions are ongoing with other countries, including through the G7, the European Commission and the World Health Organization to shape the approach taken around the world to sharing health status for travel.

The Vaccines Taskforce and the Medicines and Healthcare products Regulatory Agency (MHRA) are working with Novavax to help ensure their COVID-19 vaccine is authorised as quickly as possible. The decision to license a vaccine is made by the MHRA.